Shawn E. McCandless

Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease

Marc Nicolino, Barry J. Byrne, J. Edmund Wraith et al. · Genetics in Medicine · 2009 · 292 citations · Full text

Pharmacy, Pediatrics, Pharmacotherapy +6

The tandem mass spectrometry newborn screening experience in North Carolina: 1997–2005

Dianne M. Frazier, David S. Millington, Shawn E. McCandless et al. · Journal of Inherited Metabolic Disease · 2006 · 244 citations

Medicine, Child Health, Pediatrics +16

The Burden of Genetic Disease on Inpatient Care in a Children’s Hospital

Shawn E. McCandless, Jeanne W. Brunger, Suzanne B. Cassidy · The American Journal of Human Genetics · 2004 · 241 citations · Full text

Public Health, Genetics, Pediatrics +16

Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Mutations Identified by MS/MS-Based Prospective Screening of Newborns Differ from Those Observed in Patients with Clinical Symptoms: Identification and Characterization of a New, Prevalent Mutation That Results in Mild MCAD Deficiency*

Brage Storstein Andresen, Steve F. Dobrowolski, Linda P. O’Reilly et al. · The American Journal of Human Genetics · 2001 · 233 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome)

Joseph Muenzer, Müge Güçsavaş‐Çalıkoğlu, Shawn E. McCandless et al. · Molecular Genetics and Metabolism · 2006 · 215 citations

Life Sciences, Biochemistry, Clinical Biochemistry +8